Modelling population-level impact to inform target product profiles for childhood malaria vaccines
Sign Up to like & getrecommendations! Published in 2018 at "BMC Medicine"
DOI: 10.1186/s12916-018-1095-6
Abstract: BackgroundThe RTS,S/AS01 vaccine for Plasmodium falciparum malaria demonstrated moderate efficacy in 5–17-month-old children in phase 3 trials, and from 2018, the vaccine will be evaluated through a large-scale pilot implementation program. Work is ongoing to… read more here.
Keywords: impact; efficacy; initial efficacy; vaccine ... See more keywords